Results 141 to 150 of about 4,498 (153)
Some of the next articles are maybe not open access.
Targeting CCL24 in primary sclerosing cholangitis with CM101: rationale and study design
Journal of Hepatology, 2023Douglas Thorburn +9 more
openaire +1 more source
Abstract B018: CCL24+ monocytes drives resistance to anti-PD-L1 blockade in hepatocellular carcinoma
Cancer Immunology ResearchAbstract Background: Immunotherapy has promising anti-tumor activity in patients with advanced Hepatocellular carcinoma (HCC). However, the objective response rate of PD-L1 blockade is limited. Therefore, there is an urgent need to explore resistance mechanisms in immunotherapy.
HAIJING DENG +9 more
openaire +1 more source

